Validation of COVID-19 Insights 70% of novel gene targets identified to be associated with serious disease and hospitalization with…
2/03/22The blockbuster model for drug discovery and development in chronic diseases is inefficient and costly. We need a new…
12/10/21Unique approach to precision medicine could reverse the trend in Alzheimer’s disease drug discovery and development Clinical trials in…
27/09/21A Q&A with PrecisionLife Executive Chairman Ray Pawlicki reflecting on a senior leadership career that moved from Pepsico, to…
24/06/21by Jason Sardell, Ph.D. Statistical/Population Geneticist
7/06/21PrecisionLife recognizes the privilege and responsibility inherent in working with patient and customer datasets and is wholly committed to…
6/04/21PrecisionLife brings new insight into chronic disease biology through its unique patented combinatorial analytics platform.
25/03/21PrecisionLife brings new insight into chronic disease biology through its unique patented combinatorial analytics platform.
10/03/21PrecisionLife brings new insight into chronic disease biology through its unique patented combinatorial analytics platform.
23/02/21
